For protocol and general information on the MINDACT trial:

General MINDACT Contact for EORTC at: mindact@eortc.be

For information on the MammaPrint assay, please contact: Agendia Customer Care



Clinical Trials Information

Please visit http://clinicaltrials.gov for additional information, including eligibility criteria and a schema of the pre-registration, registration and randomization process.  Refer to this study by its ClinicalTrials.gov identifier: NCT00433589.

 

 

Sponsoring

EORTC is the legal European Sponsor for the MINDACT trial, unless otherwise specified for legal or logistical reasons.

 

Financial support has primarily been provided by:

  • Novartis
  • F. Hoffman La Roche
  • Sanofi-Aventis
  • The European Commission Framework Programme VI (FP6-LSHC-CT-2004-503426)
  • The NCI (through the EORTC) and Charitable trusts including the Breast Cancer Research Foundation
  • The Jacqueline Seroussi Memorial Foundation
  • The Prix Mois du Cancer du Sein 
  • Agendia BV